What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

被引:25
作者
Aneja, Rajesh [1 ]
Carcillo, Joseph A. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Crit Care Med & Pediat, Pittsburgh, PA USA
关键词
D O I
10.1136/adc.2005.088450
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Recent studies show that children who die from fulminant meningococcaemia have very low cortisol: adrenocorticotrophic hormone (ACTH) ratios within the first 8 h of presentation to emergency facilities compared with survivors. This observation supports the possibility that adrenal insufficiency may contribute to rapid cardiovascular collapse in these children. In recent years, the use of hydrocortisone treatment has become increasingly popular in the care of adult and paediatric patients with septic shock. In this review, the classical adrenal insufficiency literature is presented and the existing rationale for using titrated hydrocortisone treatment (2-50 mg/kg/day) to reverse catecholamine-resistant shock in children who have absolute adrenal insufficiency (defined by peak cortisol level < 18 mu g/dl after ACTH challenge) or pituitary, hypothalamic or adrenal axis insufficiency is provided. In addition, the concept of relative adrenal insufficiency (basal cortisol < 18 mu g/dl but a peak response to ACTH < 9 mg/dl) is reviewed. Although there is a good rationale supporting the use of 7 days of low-dose hydrocortisone treatment (about 5 mg/kg/day) in adults with this condition and catecholamine resistant septic shock, the paediatric literature suggests that it is prudent to conduct more studies before recommending this approach in children.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 61 条
[1]  
Addison T., 1849, London Med Gazette, V43, P517
[2]  
Aldrich TB., 1901, American Journal of Physiology-Legacy Content, V5, P457, DOI [10.1152/ajplegacy.1901.5.7.457, DOI 10.1152/AJPLEGACY.1901.5.7.457]
[3]  
Annane D, 2003, JAMA-J AM MED ASSOC, V289, P43, DOI 10.1001/jama.289.1.43-b
[4]   ICU physicians should abandon the use of etomidate! [J].
Annane, D .
INTENSIVE CARE MEDICINE, 2005, 31 (03) :325-326
[5]   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin [J].
Annane, D ;
Sébille, V ;
Troché, G ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1038-1045
[6]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[7]   Adrenal functions in patients with sepsis [J].
Aygen, B ;
Inan, M ;
Doganay, M ;
Kelestimur, F .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (03) :182-186
[8]   Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function [J].
Berneis, K ;
Staub, JJ ;
Gessler, A ;
Meier, C ;
Girard, J ;
Müller, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) :5470-5475
[9]  
Blackmon LR, 2002, PEDIATRICS, V109, P330
[10]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658